These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31819769)

  • 21. Life-threatening bullous dermatoses: Pemphigus vulgaris.
    Ruocco E; Baroni A; Wolf R; Ruocco V
    Clin Dermatol; 2005; 23(3):223-6. PubMed ID: 15896536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Number II. Pemphigus vulgaris.
    Black M; Mignogna MD; Scully C
    Oral Dis; 2005 May; 11(3):119-30. PubMed ID: 15888101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pemphigus in Australia: Aligning current practises with global recommendations.
    Somerville E; Gebauer K; Mclean-Tooke A
    Australas J Dermatol; 2022 May; 63(2):190-196. PubMed ID: 35184283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
    Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
    Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of pemphigus.
    Tsuruta D; Ishii N; Hashimoto T
    Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Pemphigus Vulgaris.
    Cholera M; Chainani-Wu N
    Adv Ther; 2016 Jun; 33(6):910-58. PubMed ID: 27287854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective cell-cell adhesion in the epidermis.
    Stanley JR
    Ciba Found Symp; 1995; 189():107-20; discussion 120-3, 174-6. PubMed ID: 7587627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the understanding and treatment of pemphigus and pemphigoid.
    Yamagami J
    F1000Res; 2018; 7():. PubMed ID: 30228865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune aspects of pemphigus vulgaris and mucosal pemphigoid.
    Sciubba JJ
    Adv Dent Res; 1996 Apr; 10(1):52-6. PubMed ID: 8934925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
    Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bullous autoimmune diseases of the oral mucosa].
    Vaillant L
    Rev Stomatol Chir Maxillofac; 1999 Oct; 100(5):230-9. PubMed ID: 10604215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients.
    Saleh MA; Salem H; El Azizy H
    Indian J Dermatol; 2017; 62(1):47-51. PubMed ID: 28216725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris.
    Sinistro A; Calabresi V; Lupi F; Sera F; Frezzolini A; Ruffelli M; De Pità O; Camaioni D; Cianchini G; Di Zenzo G
    Eur J Dermatol; 2015; 25(6):578-85. PubMed ID: 26552329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid.
    Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R
    Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunodiagnosis of pemphigus and mucous membrane pemphigoid.
    Challacombe SJ; Setterfield J; Shirlaw P; Harman K; Scully C; Black MM
    Acta Odontol Scand; 2001 Aug; 59(4):226-34. PubMed ID: 11570526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in pemphigus.
    Hebert V; Joly P
    Immunotherapy; 2018 Jan; 10(1):27-37. PubMed ID: 29064314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses.
    Grootenboer-Mignot S; Descamps V; Picard-Dahan C; Nicaise-Roland P; Prost-Squarcioni C; Leroux-Villet C; Champagnat C; Delaval A; Aucouturier F; Crickx B; Chollet-Martin S
    Br J Dermatol; 2010 Apr; 162(4):743-50. PubMed ID: 19886889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mucosal anomalies in autoimmune bullous diseases].
    Meijer JM; Vissink A
    Ned Tijdschr Tandheelkd; 2023 May; 130(5):237-241. PubMed ID: 37157989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.